Chest
DIAGNOSIS AND MANAGEMENT OF LUNG CANCER: ACCP GUIDELINES (2ND EDITION)Bronchioloalveolar Lung Cancer: ACCP Evidence-Based Clinical Practice Guidelines (2nd Edition)
Section snippets
Materials and Methods
The diagnosis, staging, physiologic evaluation, and treatment of NSCLC are thoroughly covered in other guideline chapters. Therefore, the clinical questions in this guideline were chosen to focus on areas in which there are important differences between BAC and other forms of NSCLC.
These guidelines are restricted to patients with known or suspected “pure BAC” as defined in the 1999 WHO revised classification for lung tumors. This classification system requires that the term bronchioloalveolar
Are There Distinctive Clinical and Epidemiologic Features of Patients With BAC? Are There Prognostic Differences Between BAC and Other NSCLC Histologic Subtypes?
Compared with patients who have other forms of lung cancer, patients with BAC are more likely to be nonsmokers (although smokers are at increased risk for all forms of lung cancer, regardless of histology) or have a minimal smoking history. The proportion of patients who have BAC and are female is closer to 50% and is higher than in other histologic types of lung cancer, and the occurrence of nodal spread and extrathoracic metastasis is much less than in other forms of NSCLC.5
The pathologic
Recommendations
1. We recommend that the use of the term bronchioloalveolar carcinoma be reserved for lung cancers that meet the criteria established in the revised WHO classification system for lung tumors. Grade of recommendation, 1B
2. For patients with suspected BAC, we recommend that a surgical biopsy be used to establish a histopathologic diagnosis. Grade of recommendation, 1C
Recommendation
3. For patients who are unable to undergo surgical biopsy, the diagnosis of BAC should be made only with compatible histopathologic pattern on transbronchial or core needle biopsy and a CT demonstrating a pure ground-glass or pneumonic appearance. Grade of recommendation, 1C
Recommendation
4. For patients whose CT scans show ground-glass attenuation or pneumonic consolidation (suggesting BAC), PET scans often show false-negative results, and therefore we recommend that a PET scan with negative results be followed by additional diagnostic testing to exclude the presence of cancer. Grade of recommendation, 1C
Recommendation
5. In patients who have suspected BAC and are good surgical candidates, a sublobar resection may be appropriate, provided that the CT scan shows a pure ground-glass appearance, intraoperative pathologic consultation confirms pure BAC without evidence of invasion, and surgical margins are free of disease. Grade of recommendation, 1B
Recommendation
6. For patients with good PS and unresectable BAC, we recommend the use of standard chemotherapy. The use of first-line EGFR-targeted agents should be reserved for patients with poor PS or those who are enrolled in clinical trials. Grade of recommendation, 2C
Conclusions
BAC is a form of adenocarcinoma with unique clinical, radiologic, and epidemiologic features. Hints that the presence of BAC should be considered frequently come from findings of a pure ground-glass nodule or nodules on a CT scan. Alternatively, the presence of a pneumonic consolidation that does not respond to pneumonia therapy should raise BAC in the differential diagnosis. With the notable exception of a lower likelihood of positive PET scan results in the presence of BAC, staging,
References (63)
- et al.
The epidemiology of bronchioloalveolar carcinoma over the past two decades: analysis of the SEER database
Lung Cancer
(2004) - et al.
Prognostic value of histology in patients with non-small cell lung cancer
Lung Cancer
(1997) - et al.
Prognostic significance of percentage of bronchioloalveolar pattern in adenocarcinomas of the lung
Ann Diagn Pathol
(2001) - et al.
“Early” peripheral lung cancer: prognostic significance of ground glass opacity on thin-section computed tomographic scan
Ann Thorac Surg
(2002) - et al.
Bronchioloalveolar carcinoma of the lung 3 centimeters or less in diameter: a prognostic assessment
Ann Thorac Surg
(2004) - et al.
Clinicopathological analysis of prognostic factors in clinical IA peripheral adenocarcinoma of the lung
Ann Thorac Surg
(2003) - et al.
Clinical pattern and pathologic stage but not histologic features predict outcome for bronchioloalveolar carcinoma
Ann Thorac Surg
(2002) Pathology of lung cancer
Clin Chest Med
(2002)- et al.
Long-term survival differences for bronchiolo-alveolar carcinoma patients with ipsilateral intrapulmonary metastasis at diagnosis
Ann Oncol
(2006) - et al.
The bronchioloalveolar carcinoma and peripheral adenocarcinoma spectrum of diseases
J Thorac Oncol
(2006)
PET imaging in patients with bronchioloalveolar cell carcinoma
Lung Cancer
Bronchioloalveolar lung carcinoma: results of surgical treatment and prognostic factors
Chest
Bronchioloalveolar carcinoma of the lung: recurrences and survival in patients with stage I disease
J Thorac Cardiovasc Surg
Early results of a prospective study of limited resection for bronchioloalveolar adenocarcinoma of the lung
Ann Thorac Surg
Results of wedge resection for focal bronchioloalveolar carcinoma showing pure ground-glass attenuation on computed tomography
Ann Thorac Surg
Prospective study of thoracoscopic limited resection for ground-glass opacity selected by computed tomography
Ann Thorac Surg
Correlation between lymph node micrometastasis and histologic classification of small lung adenocarcinomas, in considering the indication of limited surgery
Lung Cancer
Intentional limited pulmonary resection for peripheral T1 N0 M0 small-sized lung cancer
J Thorac Cardiovasc Surg
‘Targeting’ the epidermal growth factor receptor tyrosine kinase with gefitinib (Iressa) in non-small cell lung cancer (NSCLC)
Semin Cancer Biol
Skin rash and bronchoalveolar histology correlates with clinical benefit in patients treated with gefitinib as a therapy for previously treated advanced or metastatic non-small cell lung cancer
Lung Cancer
Gefitinib as first-line, compassionate use therapy in patients with advanced non-small-cell lung cancer
Lung Cancer
Video-assisted thoracic surgery for pure ground-glass opacities 2 cm or less in diameter
Ann Thorac Surg
Histologic examination of a case of cancer of the lung (epithelioma)
Arch Physiol Norn Pathol
Bronchiolo-alveolar carcinoma
Adv Intern Med
The changing pattern of lung carcinoma
Cancer
Rising incidence of bronchioloalveolar lung carcinoma and its unique clinicopathologic features
Cancer
Small adenocarcinoma of the lung: histologic characteristics and prognosis
Cancer
Evaluation of radiological and pathological prognostic factors in surgically-treated patients with bronchoalveolar carcinoma
Eur J Cardiothorac Surg
Impact of size, histology, and gender on stage IA non-small cell lung cancer
Asian Cardiovasc Thorac Ann
Evolving concepts in the pathology and computed tomography imaging of lung adenocarcinoma and bronchioloalveolar carcinoma
J Clin Oncol
Quantification of ground-glass opacity on high-resolution CT of small peripheral adenocarcinoma of the lung: pathologic and prognostic implications
AJR Am J Roentgenol
Cited by (0)
The author has reported to the ACCP that no significant conflicts of interest exist with any companies/organizations whose products or services may be discussed in this article.
Reproduction of this article is prohibited without written permission from the American College of Chest Physicians (www.chestjournal.org/misc/reprints.shtml)